News | October 13, 2022
Celanese support the sustained-release drug delivery market
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
Subscribe To Our Newsletter & Stay Updated
